A Study of SY-1365 in Adult Patients With Advanced Solid Tumors

NCT03134638 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

107

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision

Conditions

Advanced Solid Tumors
Ovarian Cancer
Breast Cancer

Interventions

DRUG: SY-1365 (Part 1)
DRUG: Carboplatin
DRUG: Fulvestrant
DRUG: SY-1365 (Cohort 2)
DRUG: SY-1365 (Cohort 5)
DRUG: SY-1365 (Part 2 Single Agent)

Sponsor

Syros Pharmaceuticals